Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Apr 23, 17:19

BioNTech (BNTX) to Announce Q1 2025 Financial Results

BioNTech SE
Webhose 2025 Apr 23, 17:19

BioNTech (BNTX) Advances Cancer Treatment Trials and IP Defense

BioNTech SE
Webhose 2025 Apr 23, 10:48

Q1 Earnings Forecast for BioNTech Issued By Leerink Partnrs

BioNTech SE
Webhose 2025 Apr 23, 08:42

Marshall Wace LLP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 22, 12:01

BioNTech SE to Announce Q1 2025 Financial Results | BNTX stock news

BioNTech SE
Webhose 2025 Apr 22, 11:05

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | The Manila Times

BioNTech SE
Webhose 2025 Apr 21, 20:37

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

BioNTech SE
Webhose 2025 Apr 21, 09:00

Bridgewater Associates LP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 19, 11:40

BioNTech SE (NASDAQ:BNTX) Shares Sold by Capital International Inc. CA

BioNTech SE
Webhose 2025 Apr 18, 10:01

Finward Bancorp Makes New Investment in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 18, 07:26

What the Newest mRNA Vaccines Could Do Beyond COVID

BioNTech SE
Webhose 2025 Apr 14, 17:34

BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last Week

BioNTech SE
Webhose 2025 Apr 14, 17:32

BioNTech (BNTX) Dominates German Stocks Among Hedge Funds

BioNTech SE
Webhose 2025 Apr 13, 11:52

BioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLC

BioNTech SE
Webhose 2025 Apr 13, 10:27

Scotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 11, 00:00

Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com

BioNTech SE
Webhose 2025 Apr 09, 08:30

Franklin Resources Inc. Buys 133,402 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 06, 09:07

Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 19:37

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

BioNTech SE
Webhose 2025 Apr 02, 12:01

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

BioNTech SE
Webhose 2025 Apr 02, 11:07

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 06:30

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2025 Apr 01, 17:17

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

BioNTech SE
Webhose 2025 Mar 29, 15:50

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

BioNTech SE
Webhose 2025 Mar 28, 10:26

Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Mar 28, 10:17

CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers

BioNTech SE
Webhose 2025 Mar 28, 01:32

European Patent Office declares CureVac mRNA patent valid

BioNTech SE
Webhose 2025 Mar 27, 22:26

CureVac (CVAC) Surges as European Court Validates Key Patent

BioNTech SE
Webhose 2025 Mar 27, 20:47

CORRECT: CureVac Says Patent Validated in Dispute With BioNTech

BioNTech SE
Webhose 2025 Mar 25, 21:40

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts

BioNTech SE

Latest news

Frances Wang 2025 Apr 23, 16:00

Hang Seng Index Gains on Strong China GDP amid Trump Tariffs Uncertainty

Indices
Frances Wang 2025 Apr 23, 16:00

Forex news today: GBP/USD gains, USD/JPY declines, EUR/USD strengthens

Forex
Frances Wang 2025 Apr 23, 16:00

Trending stocks to watch: AMD, GOOG, NVDA, AMZN, MSFT

Stocks
Tommy Yap 2025 Apr 23, 16:00

Morning Note: Tariff Deadlock Grips US-China Trade; Alphabet's Report Looms; BOJ Dilemma

Morning Note Tech
Frances Wang 2025 Apr 22, 16:00

Commodity market today: Crude Oil Fluctuates as OPEC+ Modifies Production Goals

Commodities
Tommy Yap 2025 Apr 22, 16:00

Morning Note: Trump Calms Fed Fears; Tesla Disappoints; UK Trade Talks Begin

Morning Note Tech
Frances Wang 2025 Apr 21, 16:00

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Stocks Indices
Tommy Yap 2025 Apr 21, 16:00

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Morning Note Stocks Commodities

Info

Spread

0.8925

Spread (%)

0.7439 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

27604328448

instr__shares_outstand

240392992

instr__earnings_date

0000-00-00

instr__dividend_date

2022-06-17

instr__ex_dividend_date

2022-06-02

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-3.47

instrument_learn_more

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments
Trustpilot